Cognitive Impairment Search Strategy

  • Initial references prior to update- 26
  • Search results of literature retrieved 5/1/2008-02/28/2014
  • PubMed:
  • (Therapy/Broad[filter] OR systematic[sb]) AND (Cognition Disorders[majr] OR "Chemobrain" OR "chemo brain" OR "Cognitive dysfunction*" OR "cognitive impairment*" OR "cognitive deficit*" OR "cognitive disturbance*" OR neurocognitive[ti]) AND (chemotherapy* OR erythropoietin OR "epoetin alfa" OR cancer OR oncolog* OR neoplasms[majr])
  • Filters activated: Publication date from 2008/05/01 to 2014/02/28
  • 652 citations retrieved
  • (MM "Cognition Disorders" OR "chemobrain" OR "chemo brain" OR "Cognitive dysfunction*" OR "cognitive impairment*" OR "cognitive deficit*" OR "cognitive disturbance*" OR TI neurocognitive) AND (chemotherap* OR erythropoietin OR "Epoetin Alfa" OR cancer OR oncolog* OR neoplasms)
  • Published Date: 20080501-20140228
  • English Language
  • Human
  • 240 citations retrieved
  • 67 titles selected from review of abstracts for full article review
  • 26 final studies included after removal of duplicates and studies that did not meet inclusion criteria, and addition of manuscripts retrieved in other topics meeting topic specific criteria
Inclusion Criteria: 
1. Full research report, systematic review, guideline or meta-analysis
2. Study must report results of measurement of cognitive impairment
3. The study examines an intervention aimed at affecting the symptom of cognitive impairment
4. Study sample must include patients with cancer
Exclusion Criteria: 
1. Grey literature
2. Descriptive study 
3. Exclude studies involving pediatric or adolescent patients with cancer.
4. Studies involving long term mental function changes in individuals previously treated for cancer as adolescents or children